Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study
<p>Background: Primaquine is the only licensed drug for eradicating Plasmodium vivax hypnozoites and, therefore, preventing relapses of vivax malaria. It is a vital component of global malaria elimination efforts. Primaquine is efficacious when supervised in clinical trials, but its effective...
Päätekijät: | Douglas, NM, Poespoprodjo, JR, Patriani, D, Malloy, MJ, Kenangalem, E, Sugiarto, P, Simpson, JA, Soenarto, Y, Anstey, NM, Price, RN |
---|---|
Muut tekijät: | Garner, P |
Aineistotyyppi: | Journal article |
Julkaistu: |
Public Library of Science
2017
|
Samankaltaisia teoksia
-
Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
Tekijä: Setyadi, A, et al.
Julkaistu: (2019) -
The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
Tekijä: Thriemer, K, et al.
Julkaistu: (2020) -
High risk of Plasmodium vivax malaria following splenectomy in Papua, Indonesia
Tekijä: Kho, S, et al.
Julkaistu: (2018) -
Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
Tekijä: Agus Setyadi, et al.
Julkaistu: (2019-04-01) -
The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia.
Tekijä: Kamala Thriemer, et al.
Julkaistu: (2020-11-01)